ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 169 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $4,156,000 | -87.8% | 562,361 | -89.4% | 0.01% | -88.0% |
Q1 2016 | $33,946,000 | -3.2% | 5,312,361 | -5.3% | 0.09% | 0.0% |
Q4 2015 | $35,077,000 | -14.2% | 5,612,361 | -19.8% | 0.09% | -18.6% |
Q3 2015 | $40,880,000 | -26.8% | 7,000,000 | +3.7% | 0.11% | -18.7% |
Q2 2015 | $55,823,000 | -8.5% | 6,750,000 | -8.8% | 0.14% | -6.7% |
Q1 2015 | $60,976,000 | +6.5% | 7,400,000 | -11.2% | 0.15% | +6.4% |
Q4 2014 | $57,234,000 | +13.6% | 8,331,000 | -10.7% | 0.14% | +12.0% |
Q3 2014 | $50,387,000 | -0.7% | 9,331,000 | +17.1% | 0.12% | -4.6% |
Q2 2014 | $50,762,000 | -5.6% | 7,968,993 | +19.5% | 0.13% | -10.9% |
Q1 2014 | $53,752,000 | +125.2% | 6,668,993 | +90.5% | 0.15% | +133.3% |
Q4 2013 | $23,870,000 | +21.2% | 3,500,000 | +226.9% | 0.06% | +10.5% |
Q3 2013 | $19,702,000 | -57.0% | 1,070,752 | -59.1% | 0.06% | -59.6% |
Q2 2013 | $45,837,000 | -6.0% | 2,620,752 | -2.9% | 0.14% | -12.4% |
Q1 2013 | $48,785,000 | – | 2,698,272 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |